Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

F. Saraceni, B. Bruno, Roberto Massimo Lemoli, Giovanna Meloni, William Arcese, M. Falda, Fabio Ciceri, Emilio Paolo Alessandrino, Giorgina Specchia, Rosanna Scimè, Roberto Raimondi, A. Bacigalupo, Alberto Bosi, F. Onida, Alessandro Rambaldi, F. Bonifazi, A. Olivieri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusAccepted/In press - Sep 26 2016

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this